Status:
COMPLETED
Atopic Diseases & Human Papilloma Virus
Lead Sponsor:
Adana Numune Training and Research Hospital
Conditions:
Human Papilloma Virus
Atopic Asthma
Eligibility:
FEMALE
30-65 years
Brief Summary
Cervical cancer is an important health problem in women. Human papillomavirus (HPV) is considered the primary etiological agent of cervical cancer worldwide. Cervical cancer screening methods are prov...
Detailed Description
Patients between the ages of 30-65 with allergic complaints (sneezing, itching,runy nose, respiratory distress) were diagnosed "atopic disease" (allergic asthma, allergic rhinitis, allergic conjunctiv...
Eligibility Criteria
Inclusion
- Patients between the ages of 30-65 with allergic complaints (sneezing, itching,runy nose, respiratory distress) diagnosed "atopic disease" (allergic asthma, allergic rhinitis, allergic conjunctivitis, chronic urticaria and atopic dermatitis) by same clinician in Immunology and Allergy Department.
- Patients between the ages of 30-65 without allergic complaints
Exclusion
- Pregnant women
- women who receive immunosuppressive therapy (including chemotherapy and chronic corticosteroid therapy)
- HIV positive women
- women with cancer
- women performed hysterectomy
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT04397081
Start Date
August 1 2019
End Date
March 30 2020
Last Update
May 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Adana City Education and Research Hospital
Adana, Merkez, Turkey (Türkiye), 01100